Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
Jul. 31, 2018
Jul. 31, 2017
Current assets    
Cash and cash equivalents $ 3,803,627 $ 11,444,676
Prepaid expenses and other current assets 1,643,749 1,068,947
Investment securities 23,174,447
Total Current Assets 28,621,823 12,513,623
Property and equipment, net 1,265,662 2,410,099
Other long-term assets 358,987 309,187
Total Assets 30,246,472 15,232,909
Current liabilities    
Accounts payable and accrued liabilities 4,778,892 3,281,133
Accrued compensation related 1,070,744 114,841
Total Current Liabilities 5,849,636 3,395,974
Other long-term liabilities 1,472,630 1,140,953
Total Liabilities 7,322,266 4,536,927
Commitments and Contingencies (Note 9)
Stockholders' Equity    
Common stock authorized - 160,000,000 common shares with a par value of $0.0001, common stock issued and outstanding - 53,511,626 and 21,618,194 common shares as of July 31, 2018 and July 31, 2017, respectively 5,351 2,162
Additional paid-in capital 145,744,373 93,866,088
Warrants issued and outstanding - 8,958,059 and 9,044,740 warrants as of July 31, 2018 and July 31, 2017, respectively 11,271,327 11,775,807
Accumulated other comprehensive loss (16,024) (3,620)
Accumulated deficit (134,080,821) (94,944,455)
Total Stockholders' Equity 22,924,206 10,695,982
Total Liabilities and Stockholders' Equity $ 30,246,472 $ 15,232,909